Factors contributing to anaemia after uncomplicated Plasmodiumfalciparum malaria in children
- PMID: 19874795
- DOI: 10.1016/j.actatropica.2009.10.011
Factors contributing to anaemia after uncomplicated Plasmodiumfalciparum malaria in children
Abstract
The factors contributing to anaemia in falciparum malaria were characterized in 1261 prospectively studied children in an endemic area of southwestern Nigeria. Of these, 487 (39%) presented with anaemia (haematocrit <30%). The following were found to be independent risk factors for anaemia at presentation: age <5 years, history of illness >3 days before presentation, presence of fever, a palpable liver, >parasitaemia 10,000/microl blood, and gametocytaemia. The mean maximum fractional fall in haematocrit (FFH) after treatment was 13.8% (95% confidence interval [CI] 13-14.6) of the baseline value. This occurred 3 days after treatment began and correlated positively with enrolment haematocrit. In children whose haematocrit was >30% at enrolment, the following were found to be independent risk factors associated with subsequent development of anaemia during follow-up: age <5 years and parasitaemia > or =100,000 parasites/microl. Haematological recovery was usually complete by 4-5 weeks, but was slower in children who were anaemic at enrolment and in those with recrudescence of their infections. Half of the children with recrudescence were still anaemic at 4 weeks. These findings have implications for the control of the burden of malarial anaemia in children in sub-Saharan African countries.
Copyright 2009 Elsevier B.V. All rights reserved.
Similar articles
-
Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials.BMC Infect Dis. 2017 Dec 19;17(1):781. doi: 10.1186/s12879-017-2876-9. BMC Infect Dis. 2017. PMID: 29258448 Free PMC article.
-
A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children.Trop Med Int Health. 2006 Nov;11(11):1643-52. doi: 10.1111/j.1365-3156.2006.01726.x. Trop Med Int Health. 2006. PMID: 17054743 Clinical Trial.
-
Plasmodium falciparum gametocyte sex ratios in symptomatic children treated with antimalarial drugs.Acta Trop. 2009 Feb;109(2):108-17. doi: 10.1016/j.actatropica.2008.10.010. Epub 2008 Nov 5. Acta Trop. 2009. PMID: 19027703
-
Malaria associated anaemia, drug resistance and antimalarial combination therapy.Int J Parasitol. 2002 Dec 4;32(13):1637-43. doi: 10.1016/s0020-7519(02)00192-3. Int J Parasitol. 2002. PMID: 12435448 Review.
-
Malaria-related anaemia.Parasitol Today. 2000 Nov;16(11):469-76. doi: 10.1016/s0169-4758(00)01774-9. Parasitol Today. 2000. PMID: 11063857 Review.
Cited by
-
The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology.Blood. 2011 Jan 13;117(2):381-92. doi: 10.1182/blood-2010-04-202911. Epub 2010 Sep 17. Blood. 2011. PMID: 20852127 Free PMC article. Review.
-
Anaemia in a phase 2 study of a blood stage falciparum malaria vaccine.Malar J. 2011 Jan 19;10:13. doi: 10.1186/1475-2875-10-13. Malar J. 2011. PMID: 21247484 Free PMC article. Clinical Trial.
-
Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.BMC Infect Dis. 2016 Jun 1;16:240. doi: 10.1186/s12879-016-1565-4. BMC Infect Dis. 2016. PMID: 27246468 Free PMC article. Clinical Trial.
-
The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians.BMC Infect Dis. 2019 Mar 12;19(1):250. doi: 10.1186/s12879-019-3862-1. BMC Infect Dis. 2019. PMID: 30871496 Free PMC article. Clinical Trial.
-
Therapeutic efficacy and effects of artemether-lumefantrine and artesunate-amodiaquine coformulated or copackaged on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in Southwest Nigeria.Am J Trop Med Hyg. 2011 May;84(5):813-9. doi: 10.4269/ajtmh.2011.10-0582. Am J Trop Med Hyg. 2011. PMID: 21540395 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical